Oncology Services for Cancer Treatment

Companion diagnostics is becoming a key element in cancer treatment. New predictive biomarkers and molecular strategies for personalized cancer therapies are currently available to treat each individual patient depending on the genetic characteristics of its tumor. Apollon Bioteck manufactures and promotes ready to use IVD assays for companion Diagnostics. These assays are based on innovative technologies such as new-generation sequencing, DNA chips and real-time PCR.